| AML | Acute myeloid leukemia |
| APAF1 | Apoptotic peptidase activating factor |
| BAX | Bcl-2-associated X protein |
| BCL2 | B-cell lymphoma 2 |
| BNIP | BCL2 Interacting Protein |
| c-IAP | Cellular inhibitor of apoptosis |
| DAPK1 | Death-associated protein kinase 1 |
| DR | Death receptor |
| E2 | Estradiol |
| ER | Estrogen receptor |
| ERK | Extracellular signal-regulated kinase |
| ERM | Estrogen receptor alpha methylation |
| GATA-1 | GATA-binding factor 1 |
| HDAC | Histone deacetylase |
| hPSC | Human pluripotent stem cell |
| HSC | Hematopoietic stem cell |
| IRF4 | Interferon regulatory factor 4 |
| JAK2 | Janus kinase 2 |
| LSC | Leukemia stem cell |
| LT-HSC | Long term hematopoietic stem cell |
| MPN | Myeloproliferative neoplasm |
| MPP | Multipotent progenitor |
| mTOR | Mammalian target of rapamycin |
| NFκB | Nuclear factor kappa B |
| PARP | Poly (ADP-ribose) polymerase |
| PBMC | Peripheral blood mononuclear cell |
| ROS | Reactive oxygen species |
| SERM | Selective estrogen receptor modulator |
| SMAC | Second mitochondria-derived activator of caspase |
| TCGA | The Cancer Genome Atlas |
| TRAIL | TNF-related apoptosis-inducing ligand |
| UCB | Umbilical cord blood cells |
| XIAP | X-linked inhibitor of apoptosis protein |